Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease

Brain Research

Volumn 889, Issue 1-2, 2001, Pages 247-250

  Sáez Valero, Javier ^a   Small, David Henry ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Cerebrospinal fluid; Diagnosis; Glycosylation

Indexed keywords

CHOLINESTERASE;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CALCIUM CHANNELS, L-TYPE; GLYCOSYLATION; HUMANS; ISOENZYMES;

EID: 0035910329     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03144-9     Document Type: Article

References (23)

1. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - A study of molecular forms
2. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type, selective loss of the intermediate (10S) form
3. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system
4. Consensus report of the working group on: "Molecular and biochemical markers of Alzheimer's disease"
5. Distribution of the molecular forms of acetylcholinesterase in human brain: Alterations in dementia of the Alzheimer type
6. Enzyme histochemical studies of senile plaques
7. Cholinesterases and the pathology of Alzheimer disease
8. Biomarkers of Alzheimer disease
9. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: A study in Japan
10. Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: Absence at birth, development during the life span, and dissolution in Alzheimer's disease
11. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia
12. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry forAlzheimer's Disease (CERAD)
13. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains
14. Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain
15. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
16. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease
17. Altered glycosylation of acetylcholinesterase in Alzheimer lumbar cerebrospinal fluid
18. An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
19. The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells
20. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease
21. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease
22. Senile plaques: Staining for acetylcholinesterase and A4 protein: A comparative study in the hippocampus and entorhinal cortex
23. Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles and patterns of selective vulnerability